China Remicade Biosimilar Market Research Report 2018

China Remicade Biosimilar Market Research Report 2017

1 Remicade Biosimilar Overview

1.1 Product Overview and Scope of Remicade Biosimilar

1.2 Classification of Remicade Biosimilar by Product Category

1.2.1 China Remicade Biosimilar Sales (K Units) Comparison by Type (2012-2022)

1.2.2 China Remicade Biosimilar Sales (K Units) Market Share by Type in 2016

1.2.3 100mg/10ml

1.2.4 500mg/50ml

1.3 China Remicade Biosimilar Market by Application/End Users

1.3.1 China Remicade Biosimilar Sales (K Units) and Market Share Comparison by Applications (2012-2022)

1.3.2 Blood Disorders

1.3.3 Oncology Diseases

1.4 China Remicade Biosimilar Market by Region

1.4.1 China Remicade Biosimilar Market Size (Million USD) Comparison by Region (2012-2022)

1.4.2 South China Remicade Biosimilar Status and Prospect (2012-2022)

1.4.3 East China Remicade Biosimilar Status and Prospect (2012-2022)

1.4.4 Southwest China Remicade Biosimilar Status and Prospect (2012-2022)

1.4.5 Northeast China Remicade Biosimilar Status and Prospect (2012-2022)

1.4.6 North China Remicade Biosimilar Status and Prospect (2012-2022)

1.4.7 Central China Remicade Biosimilar Status and Prospect (2012-2022)

1.5 China Market Size (Sales and Revenue) of Remicade Biosimilar (2012-2022)

1.5.1 China Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2022)

1.5.2 China Remicade Biosimilar Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Remicade Biosimilar Market Competition by Players/Manufacturers

2.1 China Remicade Biosimilar Sales and Market Share of Key Players/Manufacturers (2012-2017)

2.2 China Remicade Biosimilar Revenue and Share by Players/Manufacturers (2012-2017)

2.3 China Remicade Biosimilar Average Price (USD/Unit) by Players/Manufacturers (2012-2017)

2.4 China Remicade Biosimilar Market Competitive Situation and Trends

2.4.1 China Remicade Biosimilar Market Concentration Rate

2.4.2 China Remicade Biosimilar Market Share of Top 3 and Top 5 Players/Manufacturers

2.4.3 Mergers & Acquisitions, Expansion in China Market

2.5 China Players/Manufacturers Remicade Biosimilar Manufacturing Base Distribution, Sales Area, Product Types

3 China Remicade Biosimilar Sales and Revenue by Region (2012-2017)

3.1 China Remicade Biosimilar Sales (K Units) and Market Share by Region (2012-2017)

3.2 China Remicade Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)

3.3 China Remicade Biosimilar Price (USD/Unit) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"

4.1 China Remicade Biosimilar Sales (K Units) and Market Share by Type/ Product Category (2012-2017)

4.2 China Remicade Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)

4.3 China Remicade Biosimilar Price (USD/Unit) by Type (2012-2017)

4.4 China Remicade Biosimilar Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"

5.1 China Remicade Biosimilar Sales (K Units) and Market Share by Application (2012-2017)

5.2 China Remicade Biosimilar Sales Growth Rate (%) by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 China Remicade Biosimilar Players/Suppliers Profiles and Sales Data

6.1 Teva Pharmaceutical Industries

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Remicade Biosimilar Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Teva Pharmaceutical Industries Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.1.4 Main Business/Business Overview

6.2 Synthon Pharmaceuticals

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Remicade Biosimilar Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.2.4 Main Business/Business Overview

6.3 LG Life Sciences

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Remicade Biosimilar Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 LG Life Sciences Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.3.4 Main Business/Business Overview

6.4 Novartis (Sandoz)

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Remicade Biosimilar Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Novartis (Sandoz) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.4.4 Main Business/Business Overview

6.5 Celltrion

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Remicade Biosimilar Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Celltrion Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.5.4 Main Business/Business Overview

6.6 Biocon

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Remicade Biosimilar Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Biocon Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.6.4 Main Business/Business Overview

6.7 Hospira

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Remicade Biosimilar Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Hospira Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.7.4 Main Business/Business Overview

6.8 Merck Serono (Merck Group)

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Remicade Biosimilar Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.8.4 Main Business/Business Overview

6.9 Biogen idec Inc.

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Remicade Biosimilar Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Biogen idec Inc. Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.9.4 Main Business/Business Overview

6.10 Genentech (Roche Group)

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Remicade Biosimilar Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Genentech (Roche Group) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

6.10.4 Main Business/Business Overview

7 Remicade Biosimilar Manufacturing Cost Analysis

7.1 Remicade Biosimilar Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Remicade Biosimilar

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Remicade Biosimilar Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Remicade Biosimilar Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 China Remicade Biosimilar Market Size (Sales and Revenue) Forecast (2017-2022)

11.1 China Remicade Biosimilar Sales (K Units), Revenue (Million USD) Forecast (2017-2022)

11.2 China Remicade Biosimilar Sales (K Units) Forecast by Type (2017-2022)

11.3 China Remicade Biosimilar Sales (K Units) Forecast by Application (2017-2022)

11.4 China Remicade Biosimilar Sales (K Units) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

Figure Global and China Market Size (Million USD) Comparison (2012-2022)

Table Remicade Biosimilar Sales (K Units) and Revenue (Million USD) Market Split by Product Type

Table Remicade Biosimilar Sales (K Units) by Application (2016-2022)

Figure Product Picture of Remicade Biosimilar

Table China Remicade Biosimilar Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)

Figure China Remicade Biosimilar Sales Volume Market Share by Types in 2016

Figure 100mg/10ml Product Picture

Figure 500mg/50ml Product Picture

Figure China Remicade Biosimilar Sales (K Units) Comparison by Application (2012-2022)

Figure China Sales Market Share (%) of Remicade Biosimilar by Application in 2016

Figure Blood Disorders Examples

Table Key Downstream Customer in Blood Disorders

Figure Oncology Diseases Examples

Table Key Downstream Customer in Oncology Diseases

Figure South China Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)

Figure East China Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest China Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)

Figure Northeast China Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)

Figure North China Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)

Figure Central China Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2022)

Figure China Remicade Biosimilar Revenue (Million USD) and Growth Rate (%)(2012-2022)

Table China Remicade Biosimilar Sales of Key Players/Manufacturers (2012-2017)

Table China Remicade Biosimilar Sales Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Remicade Biosimilar Sales Share (%) by Players/Manufacturers

Figure 2017 China Remicade Biosimilar Sales Share (%) by Players/Manufacturers

Table China Remicade Biosimilar Revenue by Players/Manufacturers (2012-2017)

Table China Remicade Biosimilar Revenue Market Share (%) by Players/Manufacturers (2012-2017)

Figure 2016 China Remicade Biosimilar Revenue Market Share (%) by Players/Manufacturers

Figure 2017 China Remicade Biosimilar Revenue Market Share (%) by Players/Manufacturers

Table China Market Remicade Biosimilar Average Price of Key Players/Manufacturers (2012-2017)

Figure China Market Remicade Biosimilar Average Price of Key Players/Manufacturers in 2016

Figure China Remicade Biosimilar Market Share of Top 3 Players/Manufacturers

Figure China Remicade Biosimilar Market Share of Top 5 Players/Manufacturers

Table China Players/Manufacturers Remicade Biosimilar Manufacturing Base Distribution and Sales Area

Table China Players/Manufacturers Remicade Biosimilar Product Category

Table China Remicade Biosimilar Sales (K Units) by Regions (2012-2017)

Table China Remicade Biosimilar Sales Share (%) by Regions (2012-2017)

Figure China Remicade Biosimilar Sales Share (%) by Regions (2012-2017)

Figure China Remicade Biosimilar Sales Market Share (%) by Regions in 2016

Table China Remicade Biosimilar Revenue (Million USD) and Market Share by Regions (2012-2017)

Table China Remicade Biosimilar Revenue Market Share (%) by Regions (2012-2017)

Figure China Remicade Biosimilar Revenue Market Share (%) by Regions (2012-2017)

Figure China Remicade Biosimilar Revenue Market Share (%) by Regions in 2016

Table China Remicade Biosimilar Price (USD/Unit) by Regions (2012-2017)

Table China Remicade Biosimilar Sales (K Units) by Type (2012-2017)

Table China Remicade Biosimilar Sales Share (%) by Type (2012-2017)

Figure China Remicade Biosimilar Sales Share (%) by Type (2012-2017)

Figure China Remicade Biosimilar Sales Market Share (%) by Type in 2016

Table China Remicade Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)

Table China Remicade Biosimilar Revenue Market Share (%) by Type (2012-2017)

Figure Revenue Market Share of Remicade Biosimilar by Type (2012-2017)

Figure Revenue Market Share of Remicade Biosimilar by Type in 2016

Table China Remicade Biosimilar Price (USD/Unit) by Types (2012-2017)

Figure China Remicade Biosimilar Sales Growth Rate (%) by Type (2012-2017)

Table China Remicade Biosimilar Sales (K Units) by Applications (2012-2017)

Table China Remicade Biosimilar Sales Market Share (%) by Applications (2012-2017)

Figure China Remicade Biosimilar Sales Market Share (%) by Application (2012-2017)

Figure China Remicade Biosimilar Sales Market Share (%) by Application in 2016

Table China Remicade Biosimilar Sales Growth Rate (%) by Application (2012-2017)

Figure China Remicade Biosimilar Sales Growth Rate (%) by Application (2012-2017)

Table Teva Pharmaceutical Industries Remicade Biosimilar Basic Information List

Table Teva Pharmaceutical Industries Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Teva Pharmaceutical Industries Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Teva Pharmaceutical Industries Remicade Biosimilar Sales Market Share (%) in China (2012-2017)

Figure Teva Pharmaceutical Industries Remicade Biosimilar Revenue Market Share (%) in China (2012-2017)

Table Synthon Pharmaceuticals Remicade Biosimilar Basic Information List

Table Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Synthon Pharmaceuticals Remicade Biosimilar Sales Market Share (%) in China (2012-2017)

Figure Synthon Pharmaceuticals Remicade Biosimilar Revenue Market Share (%) in China (2012-2017)

Table LG Life Sciences Remicade Biosimilar Basic Information List

Table LG Life Sciences Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure LG Life Sciences Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2017)

Figure LG Life Sciences Remicade Biosimilar Sales Market Share (%) in China (2012-2017)

Figure LG Life Sciences Remicade Biosimilar Revenue Market Share (%) in China (2012-2017)

Table Novartis (Sandoz) Remicade Biosimilar Basic Information List

Table Novartis (Sandoz) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Novartis (Sandoz) Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Novartis (Sandoz) Remicade Biosimilar Sales Market Share (%) in China (2012-2017)

Figure Novartis (Sandoz) Remicade Biosimilar Revenue Market Share (%) in China (2012-2017)

Table Celltrion Remicade Biosimilar Basic Information List

Table Celltrion Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Celltrion Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Celltrion Remicade Biosimilar Sales Market Share (%) in China (2012-2017)

Figure Celltrion Remicade Biosimilar Revenue Market Share (%) in China (2012-2017)

Table Biocon Remicade Biosimilar Basic Information List

Table Biocon Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Biocon Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Biocon Remicade Biosimilar Sales Market Share (%) in China (2012-2017)

Figure Biocon Remicade Biosimilar Revenue Market Share (%) in China (2012-2017)

Table Hospira Remicade Biosimilar Basic Information List

Table Hospira Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Hospira Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Hospira Remicade Biosimilar Sales Market Share (%) in China (2012-2017)

Figure Hospira Remicade Biosimilar Revenue Market Share (%) in China (2012-2017)

Table Merck Serono (Merck Group) Remicade Biosimilar Basic Information List

Table Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Merck Serono (Merck Group) Remicade Biosimilar Sales Market Share (%) in China (2012-2017)

Figure Merck Serono (Merck Group) Remicade Biosimilar Revenue Market Share (%) in China (2012-2017)

Table Biogen idec Inc. Remicade Biosimilar Basic Information List

Table Biogen idec Inc. Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Biogen idec Inc. Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Biogen idec Inc. Remicade Biosimilar Sales Market Share (%) in China (2012-2017)

Figure Biogen idec Inc. Remicade Biosimilar Revenue Market Share (%) in China (2012-2017)

Table Genentech (Roche Group) Remicade Biosimilar Basic Information List

Table Genentech (Roche Group) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)

Figure Genentech (Roche Group) Remicade Biosimilar Sales (K Units) and Growth Rate (%)(2012-2017)

Figure Genentech (Roche Group) Remicade Biosimilar Sales Market Share (%) in China (2012-2017)

Figure Genentech (Roche Group) Remicade Biosimilar Revenue Market Share (%) in China (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Remicade Biosimilar

Figure Manufacturing Process Analysis of Remicade Biosimilar

Figure Remicade Biosimilar Industrial Chain Analysis

Table Raw Materials Sources of Remicade Biosimilar Major Players/Manufacturers in 2016

Table Major Buyers of Remicade Biosimilar

Table Distributors/Traders List

Figure China Remicade Biosimilar Sales (K Units) and Growth Rate (%) Forecast (2017-2022)

Figure China Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Remicade Biosimilar Price (USD/Unit) Trend Forecast (2017-2022)

Table China Remicade Biosimilar Sales (K Units) Forecast by Type (2017-2022)

Figure China Remicade Biosimilar Sales (K Units) Forecast by Type (2017-2022)

Figure China Remicade Biosimilar Sales Volume Market Share Forecast by Type in 2022

Table China Remicade Biosimilar Sales (K Units) Forecast by Application (2017-2022)

Figure China Remicade Biosimilar Sales Volume Market Share Forecast by Application (2017-2022)

Figure China Remicade Biosimilar Sales Volume Market Share Forecast by Application in 2022

Table China Remicade Biosimilar Sales (K Units) Forecast by Regions (2017-2022)

Table China Remicade Biosimilar Sales Volume Share Forecast by Regions (2017-2022)

Figure China Remicade Biosimilar Sales Volume Share Forecast by Regions (2017-2022)

Figure China Remicade Biosimilar Sales Volume Share Forecast by Regions in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources